Overjet Calculus Assist
Overjet Inc. • Radiology • 12/16/2022
Device Purpose
Overjet Calculus Assist is an AI-powered software designed to enhance dentists' ability to detect interproximal calculus on bitewing and periapical radiographs by automatically highlighting suspected deposits with bounding boxes. Clinical performance data indicates the system significantly improves reader sensitivity in calculus detection, serving as a valuable adjunctive tool in dental radiographic analysis.
Summary
Overjet Calculus Assist (OCalA) is a radiological computer-assisted detection software intended to aid professionally trained and licensed dentists in identifying interproximal calculus deposits on both bitewing and periapical dental radiographs. It functions as a concurrent-read tool, analyzing images to provide supplementary information for diagnosis, rather than replacing a comprehensive dental examination or the clinician's judgment. The system processes various digital radiograph formats (e.g., JPEG, PNG, DICOM) of at least 500x500 pixels, typically imported from existing radiographic devices or practice management systems, and is designed for use by dentists to enhance their diagnostic capabilities for tooth surfaces suspected of having calculus deposits. The device utilizes an artificial intelligence algorithm to automatically identify and outline suspected calculus on radiographs using a bounding box. Its architecture comprises a network layer for image and metadata handling, a decision layer for algorithmic image processing and annotation, and a presentation layer that displays the annotated images in a non-diagnostic viewer, allowing dentists to filter, display, hide, or edit annotations. Performance evaluations included standalone testing, which showed algorithm sensitivity for calculus detection at 74.1% for bitewing and 72.9% for periapical radiographs, with specificity at 99.4% and 99.6% respectively. A clinical reader study with 14 dentists demonstrated that using OCalA improved their detection sensitivity by approximately 9-10% (from around 75% to 84%) for both radiograph types, with a minimal decrease in specificity (0.1-0.2%), and yielded statistically significant improvements in AFROC AUC values.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the Overjet Calculus Assist algorithm differentiate between interproximal calculus and other radiopaque dental structures or artifacts, particularly in images with suboptimal quality?; What is the specific impact of the observed slight decrease in specificity (0.1-0.2%) on clinical workflow, such as the rate of false positives, and are there recommended protocols for dentists to manage these?; Could the 'polygon model scores' used for AFROC curve generation be translated into a clinically intuitive confidence score for each bounding box presented to the dentist?; Beyond pixel dimensions (500x500), what are the optimal image acquisition parameters (e.g., exposure, sensor type compatibility) for the Overjet Calculus Assist to achieve maximal sensitivity and specificity?; What are the computational requirements and processing times for the cloud-native Overjet Calculus Assist to analyze a typical set of bitewing and periapical radiographs in a real-world clinical setting?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM, SaaSBOM, HBOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Not detected in AI-generated device summary: SBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly